Ignite Creation Date:
2025-12-24 @ 7:21 PM
Ignite Modification Date:
2026-01-05 @ 10:35 AM
Study NCT ID:
NCT07008703
Status:
RECRUITING
Last Update Posted:
2025-06-06
First Post:
2024-01-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer Pain
Sponsor:
Shenyang Sunshine Pharmaceutical Co., LTD.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-27
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-28
First Submit QC Date:
None
Study First Post Date:
2025-06-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-29
Last Update Post Date:
2025-06-06
Last Update Post Date Type:
ACTUAL